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O&tiws. The present study tested the hypothesis thlll plasma 
immunoreactive endothelia concentration correlates with the se. 
verity sad extent of comnary atherosclerosis. 
ttoc@und. Plasma endothelin-I concentration is incrensed in 
patients with unstable coronary syndmmes and advanced athem 
sckrosis. This finding, together with other cllnkopathol~ic ob- 
servations, suggests that endothelins may participate in the 
atberogenk pmcess. However, tbc relation behvecn plasma immu- 
noreactive endothelin and comrary artery disease !n patients with 
stable an&m pectoris remains contmversial. 
Methods. Ninety consecutive patients undergoing comnary 
angiograpby for the investigat:on of exertional chest pain and 4Y 
normal control subjects were prospectively studid. Eleven w 
tlents bad normal comnury an&graphic tindings (group I), 65 
bad coronary artry stenoses (ylronp II), and 14 bad coronary 
artery disease piss symptoms indicating alberomu in other vas- 
cular terrttorks (group Ill). Computerixed angiography was used 
to determine the extent, severity and morphology of comnary 
_-- _____ -_._ ._- _____ “--- . ..-. ----- _.___- _-_- 
Endothelin-I is a potent vasoconstrictor pcptidc (1) that also 
has mittrgenic activity on cultured vascular smooth muscle cells 
(2). In IYYI lsrman cl 41. (3) demonstrated a significant 
cotrelation hetwccn plasma cndolhelin-I Icvels and the extent 
of advanced athcrosclcrosis, suggesting that the peptide may 
parttcipate in the athetogenic process. This intriguing hypoilr- 
esir was reinforced by subsequent experimental studies dem- 
onstrating higher plasma levels of endothelin-1 and enhanced 
endothelin-1 immunoreactivity in the coronary vessels ol 
hypetcholestcrolcmic pig+ (4) and incrcascd iodine-13 
endothclin-I binding in human athcromatous coronary arteries 
(5.0). The dc!norrhtr;ition of raised plasma cndothclin-I levels 
-___-- 
btenoscs. Plasma immunoreactive endothclin was measured by 
radioimmunoassay. 
ResuUs. Mean (*SD) plasma endot!.rtin concentration @g/ml) 
way signitkantly blgher In patients than in control subjects 
(7.29 f 4.07 vs. 3.48 + 1.29, p C 0.0001). Endothelin levels were 
b&her in patients of group III tbcn in those of groups II and I 
(9.43 f 5.48,7.20 f 3.72 and 4.94 i 2.89, respectively, p = 0.02). 
In patient3 of gmup II, plasma endothelin correlated with the 
maximal degree of stenosis in earl! patient (r = 0.25, p = 0.04) 
and with the number of stenoses dth ?70% diameter narrowing 
(r = 0.36, p = 0.002). The highest plasma endotbelio levels were 
found in patients with total occlusions (8.65 k 3.78 vs. 6.46 f 3.51, 
p = 0.02). 
Conclusions. Plasma immuooreactive endotbelin concentration 
is increased in patknts with chronic stable aagian. The highest 
levek occur in patients with severe stenoses and total comnary 
occlusion. 
(.I Am Call Caniiol1996:2d:l4-9) 
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in patients with a;ute myocardial infarction (7-9) and unstable 
angina t lt1.11) suggests that endothelins may also play a tale in 
the pathogen& of acute coronary syndromes. This postulate 
is supported by evidence from a recent study by Zeiher et al. 
(12) demonstrating enhanced endotheiin-I immunoreactivity 
III .ACIUSL~CWU, plaques obkned during atherectomy in 
patients with unstable angina. 
In spite of this evidence, the relation hctwecn plasma 
cndothclin and chronic stahlc angina remains controversial. 
Palicnts with stable angina have usually been used as control 
subjects in studies of patients with acute myocardial infarction 
or unstahlc angina. In addition, most reports have not deter- 
mined the relation between plasma endothelin and the extent 
and severity of coronary atherosclcrrGc 11, a rcch*’ * ,:xccption, 
Montulescot et al. (13) found no corrcla~ion betwcon plasma 
sndothehn-I levels and the presence or extent of coronary 
lcuion\ ;lt angiography Ilowevcr. the patient group in I leir 
<Judy was hetcrogrncous, containing only a small cohort of 
pdticnts whh stable angina and no normal control subjects. 
The aim of the present study was to measure plasma 
immunorcactivc endothclin concentration’ in well character- 
ized ron>ecutivc patients v:tth chronic stable angina pctoris 
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Table 1. Clinical Characteristics of YO Patiects With Stahlc ExcrGonal Chest ?ais . “.__ --I__ --.. 
I__--- 
ARC WI 
M;de/femalc ratio 
Weight (kg) 
hgina grading’ 
Class I 
Class II 
Class 111 
Previous Ml 
Smoking 
Currcnl 
I,SlrlllL!r 
T<Ul 
Plasma crutitinine (~mol.‘ml) 
ttyperlipidemia 
tlypcrtcn\ion 
Diilhctch mollilua 
Filmily history 
I!jcclLm In&n 
Current medication 
ACE inhibitor 
kpirin 
Beta-hlorkcr 
Czdcium antagonist 
Diuretic drug 
NlWdlC 
Normal Cbronary 
Angiqraphic 
Findin@ 
(n = II) 
>9 -? 9 
4,v 
69 2 10 
Corcmary Amy 
DkiiSC 
(I: -- bS) 
62 + 8 
53112 
7112 12 
Coronary and 
Systemic 
Athercrrler& 
(II 7 14) 
58tH- - 
II::. 
?Yt 13 
5 (464’) 35 (55%) 7 (so%) 
3 (27%) 20 (32%) 5 (3bQj 
3 (27%) N(lB!h) 2(14?) 
I (YCi) ?I (33% ) 5 (36’:) 
3(2x’;) 
4 (3fG) 
7(b4%) 
19 rt 6 
3 (27’; ) 
3 (?7?) 
II (0’; ) 
.i (4%) 
72 -? I?‘; 
Y (14$) 5 (36~i) 
2x (4X) 5 (:6’::, 
37 (56% ) IO (72%) 
w 2 22 9s f 2n 
.35 (.SS!i ) 6 (WI) 
2x (&vi , X(.57’;) 
2(K) I (Y?) 
43 (67’; , I I (7Y’r) 
bS t 13“: 71 ? 11:; 
(I (o?) I5 (7’0 0 (IFi ) 
5(4x;) s3 (XX ) 13 (93%) 
J (.%A ) 43 (MV ) 6 (43’i) 
7 (b3%) 32 (49%) 9 (bm) 
2(1&T:) 12 (xi%) 4 (?9(%) 
b (3%) 29 (454) Y (b‘f? ) 
and to determine its relation IO clinical presentation and the 
extent, severity and angiographic I&on morpholog of coro- 
nary atherosclerosis. 
Methods 
Patients and control subjects. We prospectively studied YO 
Caucasian patients (70 men and 20 women aged 61 t Y years 
[range 36 to 831) with chronic stable angina (typical exertional 
chest pain with unchanged pattern for 23 months) selected 
from 19 I consecutive patients who underwent diagnostic cor- 
onary angiography at our institution duriug November and 
December 1904. Patients with valvuiar heart disease (n = 31). 
previous cardiac surgery or coronary angioplasty (n = 57). 
renal impairment (n = 2) or cardiac failure (n = 2) were 
cxcludrd. Nine patients rcfuccd to participate in the study. 01 
the Yl) paGents included, 44 wcrc receiving trcatmcm for 
hypcrlipidemia and 30 were hypcrtcnsive (blood prcssurc 
~150/YS mm Hg) or were taking antihypcrtensivc drugs OII 
admiwion. Patient medicatious are detailed in Table I. Four- 
teen patients had clinical events icdic.!;vc of athcroma io 
other vascular territories: stroke (n = 2). transient ischcmic 
attacks (n = 2) or intcrmi&nt claudication (n = II). Patients 
were subclassified into three groups according to the prcscncc 
or absence of coronary .Irtcry disease and a clinical diagnosi> of 
athcroma in other vascular territories: RNMD I. I I salients with 
completely normal coronary angiograpiic &ingi;group II, 6.5 
patients with coronary artery stenoses (diameter reduction 
?2tJ%) but no clinical history compatible with atheroma in 
other systems; group /Ii, 14 patients with coronary artery 
stenoses (diamc ter reduction ~20%) and a clinical diagnosis 
of atherosclerosis in other organs (stroke, transient ischemic 
attacks. intsrmiti-ol claudication). 
The control group consisted of 49 normal volunteers (I7 
women and 32 met?. dged 35 ?: 7 years, range 111 to 66) with no 
history of cardiova.&ular, renal or metabolic disease. 
The study wa.i approved by the local research ethics com- 
mittee, and every patil.nt gave written informed consent before 
study entry. 
Angiograpbir aswssmcn1. Diagnostic angiography was 
performed by u,ing the Judkins technique. Coronary angiog- 
raphy wls performed by using a Philips digital angiography 
system (Philips integris HM 3001’; and standardized angio- 
graphic projections. 
The assessmen of coronary lesions was carried out by two 
cxpcrienccd observers who had no knowledge of the identity 
and clinical characteristics of the patients. The extent of 
coronary adicrosclerosis was evaluated by usinp’a previously 
validated scoring method (14). A total of IS segmeub in the 
three major coronary arteries were considered and :III narrow- 
16 SALOMONE ET AL 
ENDOTHELIN AND CORONARY ATHEROSCLEROSIS 
JAW Vol. 211 Flu. I 
July IY&:l4-Y 
ing in each segment recorded. Percent coronary narrowing 
was calculated by comparison of the minimal diamctcr (in mm) 
of the involved segment to the diameter of an adjacent 
angiogrrphically normal coronary segment. Coronary artery 
diselrs was defined by the prestmcs of stcnoses producing 
~20% diameter reduction in a major coronary vessel. Severe 
coronary steno.ses were defined as Z70% narrowing, including 
those with 100% diameter reduction (totai coronary occlu- 
sion). Left ventricular ejection fraction was assessed automat- 
ically from the right anterior oblique plane by using a conven- 
tional formula (1.5). 
Figure 1. Plasma cndothelin suncentration (mean value 2 SD) in 
patients with chronic stable angina (left) and normal control subjects 
(right). Thu large circles and bals indicate group mean values. 
Stenosis morphology. The morphology of coronary stenoses 
was visually assessed from two orthogonal projections by two 
independent, experienced cardiologists using a previously dc- 
scribed technique for the characterization of stenosis morphol- 
ogy (16). If discrepancies regarding the morphologic appear- 
ance of a lesion arose, a third observer was enrolled and the 
lesion classified by consensus. Complex lesions were dcfincd by 
one or more of the following morphologic fea!ures: 1) irregular 
or scalloped borders; 2) overhanging or abrupt edges perpen- 
dicular to the vessel wall; 3) ulceration (i.e.. outpouchings 
within the stenosis); a nd 4) the presence of filling defects 
consistent with thrombus. Concentric or eccentric plaques with 
no complex features were classified as smooth lesions. 
Results 
Cwmary arteriugraphy. Of the 90 patients studied. 79 had 
a total of 201 coronary segments with lesions of ~20% 
diameter reduction (mean per patient 4 2 2 [range I to 91). 
One hundred twenty-one severe stenoses (~70% narrowing) 
were observed in 77 patients. Of these, 27 were total occlusions 
and occurred in 27 patients. Mean ejection fraction was 70 St 
12% (range 50% to SS%). 
Endothelin assay, Venous blood was sampled from the 
antecubital vein before catheterization after a 20-min period of 
supine rest. Blood was drawn into chilled citrate tubes on ice 
and plasma was separated by centrifugation at 1,500 g for 
10 min at 4°C. This was then decanted and stored at -20°C 
until analysis. Plasma immunoreactive endothelin concentra- 
tions were estimated by using a radioimmunoassay (Nichols 
Institute, Diagnostic F3.V.. Wychen, Nctherkmds). Two millili- 
ters of plasma was acidified with 3.0 ml of 4%) acetic acid in a 
polystyrene tube mixed by vortex. Extraction was performed by 
gravity, decanting the acidified sample through a Seppak C-18 
carlridde prcli&cJ with 5 ml of 100% methanol, 5 ml distilled 
water and 5 ml 4%. acciic acid. After application of the pklsma 
the cartridge was washed with 3 ml of 25% ethanol in distilled 
water. Endorhelin wds cluted from the cartridge with 2 ml of 
4% acetic vol/vol in 86%~ ethanol into 16 X IOU-mm borosili- 
cate glass tubes The eluates were dried and reconstituted in 
SOO-~1 RIA buffer. 
There were no significant differences in the clinical charac- 
teristics, conventional risk factors and ventricular funaion of 
!he three patient groups (Table 1). Nine of the 11 patients with 
chest pain but normal coronary angiographic Endings had 
positive exercise test results (=l-mm horizontal or downslop- 
ing ST segment depression) before undergoing coronary an- 
giography. 
Plasma endothelio. Mean plasma endothelin concentra- 
tion was 7.29 + 4.07 pglml (range 1.97 to 22.87) in patients and 
3.48 -C 1.2’) pg/ml (range 1.57 to 4.48) in control subjects (p < 
0.0001) (Fig. I). Mean plasma endothelin concentrations were 
signilicantly ditTcrrnt in the three groups (4.94 t 2.89, 7.20 + 
3.72 and 9.43 +_ 5.48 p&ml in groups I, II and III, respectively, 
p = 0.02) (Fig. 2). Mean plasma endotb ” ’ *.- .‘,. ;- -11 fhr*r 
patient groups were significantly higher than in control subjects 
(p = 0.01, <O.OOOI and ~0.0001 for groups I, 11 and III, 
respcctivcly). 
Plasma endothelin levels were similar in patients with and 
without hypertension (7.20 + 4.32 and 7.46 It 3.83 pg/ml, 
The sensitivity of the assay was 2 p@ml, with IOO? cross- 
reaolivity with endothelin-I, 52cj; with cndothclin-2, 06”: for 
endolhelm-3 ;rnd 7’J for hig cndothelin. Cross-reactivity with 
atria1 .utlriurL;ic pcptitlc, angtotcnsin II. adrenocorticotrupic 
hormone nnd vaaopressin was :O. IS. The intdrasaay variahil- 
ity HitS ~.ltJ’X, 
Figure 2. Plasma cndothclin concentration (mcmt value ” SD) in 
puticnts with cxcrtiond! vh:~l pain and normal coronary angiographic 
findings (group I). corovry artery disease only (group II) and coro- 
nary ark? disease plus symplomatic atherosclerotic involvement of 
other tcrntorict (group 111). Differences between group were statis- 
tically significant (p = 0.02. Kruskal-Wallb lot). 
Data analysis. All results are reported as mean value 1 I 
SD. Statistical analy+ wah performrd hy using tw+tailcd I 
teals lor unplir2d ~J~IU~;I~~~II~ or Mann.\k~~ttncy t: tcht ilb 
appropriate. Simple linear rsgrersion unaly?tc wcrc performed 
by using biandard modsI\ ((‘-Stat for Winduw%, vcr%n I .lL, 
Oklcch 1992. Oxford, UK). The Kruskal-Wallis test was cm- 
ployed lo ecalualr differences bct*22n patirnt subgroup. A p 
value ilt.05 was accepted a\ statistical& significant. 
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FfgureJ. FGatiun of plasma endothelin concernration to the maximal 
degree of stenosis prerpnt in each patient (mean value _+ SD). There 
aie signiticant differences between groups. 
respectively, p = NS) and in patients with cholesterol levels 
25.2 mmollliter and <5.2 mmol/liter (7.10 f 3.76 and 7.42 -C 
3.42 pg/ml, respectively, p = NS). In the total study group of all 
patients with coronary artery disease, plasma endothclin did 
not correlate with ejection fraction or plasma creatinine levels. 
Plasma endothelin levels did not differ between patients who 
were former smokers or nonsmokers and those who were 
current smokers. There were no differences in plasma enio- 
thelin levels in patients taking any class of medication. 
Plasma endotbelin in patients with corooaly artery disease 
only (group II). In group II, plasma endothelin correlated 
with the maximal degree of stenosis present in each patient 
(r = 0.25, p = 0.04). The highest plasma endothelin levels were 
found in patients with total coronary occlusions (8.65 2 3.78 vs. 
6.46 2 3.51 pg/ml in patients without occhrsion, p = 0.02). 
Mean plasma endothelin cotr:~atrdtL;. :;d:, higher in patizuis 
with total coronary occlusions (X.84 t 3.96 pglml) than in 
patients with coronary stenoses ranging from 71% to 99%’ 
(mean 6.59 + 3.59 plJml, p = 0.03), 5 I% to 79% (mean 4.55 t 
3.45 pg/ml, p = 0.08) or 20% to 50% maximal narrowing 
diameter (6.22 ? 2.58 pgiml, p = 0.03) (Fig. 3). There was a 
positive correlation between plasma endothelin concentration 
and the number of stenoses with ~70% diameter reduction 
(r = 0.36. p = 0.002). 
Plasma endothelin did not correlate with the number of 
coronary segments with 220% stenosis (r == 0.14, p = 0.26). 
Plasma endothclin levels were similar in patients with complex 
coronary stenoses (n = 19) and in those with smooth stenoscs 
(n = 46) (7.27 t 3.79 vs. 7.18 _+ 3.74 pg/ml). 
In patients of group 11, plasma endothelin concentration 
correlated with ejection fraction (r = -0.37, p = O.&t). 
Patisnts with total coronary occlusions lmd a significantly lower 
cjcction fraction than did patients without total occlusions 
(64 C IO% vs. 78 2 6%, p -= tt.W2); however. no patients had 
an ejcclion traction 40%. 
Discussion 
This study shows that plasma immunorcactive endothelin 
levek are raivd in patients with chronic stable angina and. to 
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our knowledge, for the first time demonstrates a correlation 
between plasma endothelin and the severity of coronary ath- 
eroma. Lerman et al. (3) were the first to demonstrate a 
significant association between plasma endothelin-1 levels and 
the number of sites of atheroma in humans. However, they did 
not assess the severity or extent of coronary artery disease in 
their patients. The observation in the present study that 
patients with coronary atheroma and a clinical diagnosis of 
atheromatcus disease elsewhere had the highest plasma endo- 
thelin concentrations supports and extends the findings of 
Lerman et al. (3). 
Plasma eodothelio aod chror~lc stable aogloa Plasma en- 
dothelin levels have been previously assessed in patients with 
chronic stable angina (lo-l9), but the relation between plasma 
endothelin concentration and clinically stable atheroma re- 
mains controversial. The patient cohorts studied have been 
relatively small and patients with stdbte angina pectoris have 
usually been used as mntrol subjects in the investigation of 
acute coronary syndromes. For example. Ray et al. (10) found 
lower plasma endothelin-I concentrations in patients with 
stable angina than in patients with acute myocardial infarction, 
but they studied only 10 patien!s with stable coronary artery 
disease. More recently, Montalescot et al. (13) measured 
plasma endothelin levels in 45 patients undergoing cardiac 
catheterization and found no association between plasma 
endothelin-1 levels and the extent or severity of coronary 
disease in the 32 patients who underwent quantitative angio- 
graphic assessment. In contrast to the large consecutive series 
of patients with well defined exertional stable angina in the 
present report. their study group was heterogeneous (including 
patient? with stable and unstable angina), dnd normal control 
subjects were not examined. In the present investigation, the 
demonstration of significantly higher levels of plasma endotise- 
lin in patients with chronic stable angina than in normal 
persons suggests a role for this pcptidc in the pathophysiology 
of coronary atheroma. 
Role of eodotbelia in coronary atberoma In the present 
study, plasma endothelin levels correlated with the maximal 
stenosis present in each patient and with the number of 
stenoscs r70%. Furthermore, patients with total coronary 
occlusions had the highest levrle of endothelin. Zeiher et al. 
(12) observed that there is a prugrcssive impairment of 
endothclium-dependent vasodilation in patients with different 
stages of coronary artery disease ranging from a selective 
vasodilator abnormality to complete absence of endothelium- 
dependent vasodilation. The trend toward an association be- 
tween elevated plasma cndothelin levels and severe soronary 
artery discasc observed in this study may, therefore, reflect the 
degree of associattd endothelial dysfunction. Nevertheless. 
there was no significant correlation with the number of dis- 
c&cd coronary scgmcnts (Z?O% oiameter narrowing). The 
sample size may have been insu@cient to detect a significant 
difference. but another possibility, based on current pathophys- 
iologic knowledge. is that the angrographic assessment of 
coronary segments affected by atheroma may bc a poor 
mcasurc of disease activity. Furthermore, as circulating end+ 
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thclin derives from the spillover from endothelial cells (17,18). 
plasma concentrations may not directly mirror local produc- 
tion at active atheromatous sites. 
This study only examined peripheral venous endothclin 
concentrations; thus, the source of raised endothelin levels 
remains uncertain. The correlation found in this study between 
disease severity and plasma endothelin suggests that elevated 
endothelin levels are derived from coronary vessels with 
diseased endothelium. Alternatively, they may be a systemic 
risk factor predisposing to severe coronary artery disease. 
Although we found ‘an association between ejection fraction 
and plasma endothelin in our patients with coronary atheroma, 
no patient had clinical hedrt failure or an ejection fraction 
cXJ%. Thus, it is unlikely [hat left ventricular dysfunction 
contributed to the elevated plasma endothelin levels we ob- 
served. Similarly. all patients had plasma creatinine levels 
witbin the normal range, :md plasmn endothelin did not 
corrrlate with plasma creel*’ ,ine concentration. Therefore, 
inrpatred renal function is an improbable cause of elevated 
plasma endothelin conccntmtion in this imestigation. 
The precise nature of the association between endothelin 
and coronary artery discasc remains speculative. but studies 
suggeai that endothelin ma) play a role at sevcrdl slag;? of 
atheroma formation. For example, in hypercholesterolemic 
pigs, plasma levels of endotheiin-1 are elevated and endothelin-1 
immunoreactivity is enhanced in coronaF; v;asets (4). In 
humans, Dashwood et al. (5,6) demonstra ’ -: sed iodine- 
125 endothelin-1 binding in human ath .a coronary 
arteries, with the highest densitv found in me tunica media, 
vasa vasora and regicns of neovascularization. Recent work by 
Zeiher et al. (12) demonstrating enhanced endsrhelin-I immu- 
noreactivity in active athen~sclerotic plaques removed during 
athetectomy in patients with unstable angina, suggests that 
endothelin-1 may also hc associated with plaque disruption. 
Clinical evidcncc to support this Iattcr hypothesis comes from 
btudics dcrnonhtrating r&d plasma endothclin-I levels in 
patients with unstable anRma (I l,i3,19,20) and acute myocar- 
dial mfarclion (7,1 I). In tbc pre$cnt study we examined the 
relation between plasma endothelin and the angiographic 
equivalent of high risk coronary stenoses, (i.e., complex le- 
sions), and found no d:;sociation between them. This is not 
surprising, as wr (21) have previously observed that only a 
small proportion of comp!cx s&noses progress in patients with 
chronic stable angina. Thts ohcrva(ion indic;ltcs Ihat nnaio- 
graphic lc&ln morphology ;ilonc is ;I rcl.ltivcly inscnsitivc 
marker 01 plaque il&ity. 
in the present investigation, neither lipid levels nor the 
prcscncc 01 hypc’M~i,:n correlated with plasma cndothclin 
ccmccntration. Although thcrc .<re some dal;i (4) to su~c\l 
thrt ‘~yperlipidcrnia may result m mcrrastl plasmik cndothclin 
Icvck. in humans. Ihi> hypolhcais remains controvcrsiill iI> 
Endothelin and angina pectoris witb normal angiographic 
findings. This study supports the recent observation by our 
group (25) that plasma endothelin levels are elevated in 
patients with syndrome X (i.e., angina, normal coronary arte- 
riogrdphic tindings and a positive exercise test result). In the 
present study, endothelin levels were higher in patients v:ith 
angina pectoris and normal coronary angiographic data (group 
I) than in control subjects. Severa! studies (26) have shown that 
a proportion of patients with syndrome X have reduced 
coronary blood flow, and it is conceivable that plasma endo- 
thelin may have a role in microvascular dysfunction in patients 
with angina and normal acgiographic findings. An alternative 
hypothesis is that patients with angina pectoris and apparently 
normal coronary arteries have intramural disease that, al- 
though angiographically undetectable, may be sufficient to 
elevate plasma rndothelin levels and trigger endothelial dys- 
function (27.28). 
Conclusions. Plasma immunoreactive endothelin levels are 
higher in palicnts with chronic stable angirla than in norlrlai 
control subjects. A relation between plasma endothelin lsvels 
and the degree of coronary stenoses has been identified 
indicating that plasma endothelin may be a surrogate marker 
of scverc coronary a:tcry disease in patients with chronic stable 
angina. 
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